Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacific Biosciences of California Inc. buy Cantor Fitzgerald

Pacific Biosciences of California Inc.
Start price
€6.27
31.10.23 / 50%
Target price
€10.36
31.10.24
Performance (%)
-68.90%
End price
€1.95
01.11.24
Summary
This prediction ended on 01.11.24 with a price of €1.95. Massive losses of -68.90% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pacific Biosciences of California Inc. -17.746% -17.746% -12.283%
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

Comments by Cantor_Fitzgerald for this prediction

In the thread Pacific Biosciences of California Inc. diskutieren
Prediction Buy
Perf. (%) -68.90%
Target price 10.361
Change
Ends at 31.10.24

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
31.10.23
In the thread Trading Pacific Biosciences of California Inc.
Prediction Buy
Perf. (%) -68.90%
Target price 10.361
Change
Ends at 31.10.24

Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten

Cantor Fitzgerald 
0
Report Share
01.11.24

Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.

buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€1.41
08.08.24
€3.21
08.08.25
-19.66%
09.08.25

Cantor Fitzgerald 
08.08.24 50%